Investors / United Kingdom / LYVA Labs
LYVA Labs
Venture capital · Liverpool, United Kingdom · Europe
LYVA Labs invests in and supports innovative businesses in the Liverpool City Region, providing pre-seed investment to start-ups and expert-led programmes for established SMEs. It also delivers incubators, accelerators, innovation consultancy, grant funding support and consortia building.
Invests inHealthcare & Biotech
In its own wordshealthlife sciencesdeep techclean techincubatoraccelerator
Your fit with LYVA Labs
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsLYVA Labs lists 11 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (91%) and Legal & Compliance (9%). 100% of its companies are based in United Kingdom. It invests most often alongside Deepbridge Capital, Entrepreneurs First and Foresight Ventures.
Counts come from funding rounds that name LYVA Labs, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not LYVA Labs' whole history. Rounds on record name 2 companies; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 96th | 91% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Deepbridge Capital | 1 |
| Entrepreneurs First | 1 |
| Foresight Ventures | 1 |
| Freestyle | 1 |
| Haatch | 1 |
| Oxford Technology Management | 1 |
| Science Creates Ventures | 1 |
| Twin Path Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 91% | 15% |
| Legal & Compliance | 9% | 2% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Deepbridge Capital
Compare LYVA Labs head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with LYVA Labs| Date | Company | Stage |
|---|---|---|
| 11 Mar 2026 | Seed | |
| 8 Sept 2025 | Seed |
Round details for LYVA Labs
Amounts, full round histories and every co-investor in LYVA Labs' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| CureAge Therapeutics is curing peripheral nerve diseases with genetic medicine | Healthcare & Biotech | Portfolio page | ||
| Hado Therapeutics discovers and develops disease-modifying medicines | Healthcare & Biotech | Portfolio page | ||
| ImmunoKey is developing a platform technology to unlock the potential of CAR T-cell therapy for solid cancers. | Healthcare & Biotech | Portfolio page | ||
| The company pioneers a new era in the fight against life-threatening fungal infections using immunotherapy to create antifungal therapies. | Healthcare & Biotech | Portfolio page | ||
| Oppilotech simulate biology using a predictive computational modelling platform to provide insights into treating diseases. | Healthcare & Biotech | Portfolio page | ||
| Pentabind designs and licenses application-ready aptamer assets for continuous molecular sensing | Healthcare & Biotech | Portfolio page | ||
| SenseAI Vision Ltd develops and applies neural network solutions for low-dose imaging in electron microscopy and other fields. | Legal & ComplianceHealthcare & Biotech | Sept 2025Seed | Funding round | |
| Portfolio page | ||||
| Spotlight Pathology Ltd designs and provides advanced, AI-driven pathology tools to transform clinical pathology practices | Healthcare & Biotech | Mar 2026Seed | Funding round | |
| Vector Bioscience develops a machine-learning empowered drug delivery platform | Healthcare & Biotech | Portfolio page | ||
| Veirulence develops non-antibiotic small molecules that target bacterial virulence to defeat resistant infections | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- lyvalabs.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 8 Sept 2025
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get LYVA Labs' profile as data
Pull LYVA Labs' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/lyvalabs.com
# also
GET /v1/firms/lyvalabs.com/portfolio
GET /v1/firms/lyvalabs.com/coinvestors
GET /v1/firms/lyvalabs.com/news